Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.

Saved in:
Bibliographic Details
Title: Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.
Authors: Franceschi S; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Lessi F; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Aretini P; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Ortenzi V; Department of Translational Research and New Technologies in Medicine, University Hospital of Pisa, Pisa, Italy., Scatena C; Department of Translational Research and New Technologies in Medicine, University Hospital of Pisa, Pisa, Italy., Menicagli M; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., La Ferla M; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Civita P; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Zavaglia K; SOD Molecular Genetics, University Hospital of Pisa, Pisa, Italy., Scopelliti C; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy., Apollo A; Tumor Cell Biology Unit, Istituto Tumori Toscana, Florence, Italy., Carbone FG; Department of Translational Research and New Technologies in Medicine, University Hospital of Pisa, Pisa, Italy., Vannozzi R; Neurosurgery Department, University Hospital of Pisa, Pisa, Italy., Bevilacqua G; Pathological Anatomy Section, San Rossore Clinic, Pisa, Italy., Pasqualetti F; Radiotherapy Department, University Hospital of Pisa, Pisa, Italy., Naccarato AG; Department of Translational Research and New Technologies in Medicine, University Hospital of Pisa, Pisa, Italy., Mazzanti CM; Fondazione Pisana per la Scienza, Onlus, Pisa, Italy.
Source: Oncotarget [Oncotarget] 2018 May 08; Vol. 9 (35), pp. 24014-24027. Date of Electronic Publication: 2018 May 08 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.25265